Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration. Dissociation from the involvement of opioid receptors

Methods Mol Med. 2003;79:43-54. doi: 10.1385/1-59259-358-5:43.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Dopamine / metabolism*
  • Humans
  • Inflammation / metabolism
  • Naloxone / pharmacology*
  • Narcotic Antagonists / pharmacology*
  • Nerve Degeneration*
  • Neurodegenerative Diseases / metabolism
  • Neurodegenerative Diseases / prevention & control*
  • Neuroprotective Agents / pharmacology*

Substances

  • Narcotic Antagonists
  • Neuroprotective Agents
  • Naloxone
  • Dopamine